Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Abbott Laboratories

ABL
Current price
102.82 EUR +1.35 EUR (+1.32%)
Last closed 102.54 EUR
ISIN US0028241000
Sector Healthcare
Industry Medical Devices
Exchange Stuttgart Exchange
Capitalization 177 445 636 471 EUR
Yield for 12 month +12.76 %
1Y
3Y
5Y
10Y
15Y
ABL
21.11.2021 - 28.11.2021

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Address: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

35.5401

Dividend Yield

1.93 %

Current Year

+36 522 493 329 EUR

Last Year

+39 749 592 393 EUR

Current Quarter

+9 449 099 037 EUR

Last Quarter

+9 073 029 084 EUR

Current Year

+20 154 799 854 EUR

Last Year

+22 319 250 891 EUR

Current Quarter

+5 257 694 694 EUR

Last Quarter

+5 009 106 081 EUR

Key Figures ABL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 10 569 560 479 EUR
Operating Margin TTM 17.66 %
PE Ratio 35.5401
Return On Assets TTM 6.26 %
PEG Ratio 4.1354
Return On Equity TTM 14.44 %
Wall Street Target Price
Revenue TTM 40 719 455 147 EUR
Book Value 22.59 EUR
Revenue Per Share TTM
Dividend Share 2.16 EUR
Quarterly Revenue Growth YOY 4 %
Dividend Yield 1.93 %
Gross Profit TTM 24 575 653 366 EUR
Earnings per share 2.87 EUR
Diluted Eps TTM 2.87 EUR
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -5.1 %
Profit Margin 13.65 %

Dividend Analytics ABL

Champion - 10+ consecutive years of dividend increases

Dividend growth over 5 years

82 %

Continuous growth

10 years

Payout Ratio 5 years average

56 %

Dividend History ABL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 1.98
Ex Dividend Date 15.10.2024
Forward Annual Dividend Yield 1.93 %
Last Split Factor
Payout Ratio 73.5 %
Last Split Date
Dividend Date

Stock Valuation ABL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 35.5401
Forward PE 21.9298
Enterprise Value Revenue 4.9798
Price Sales TTM 4.3578
Enterprise Value EBITDA 19.5719
Price Book MRQ 5.0125

Financials ABL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ABL

For 52 weeks

84.15 EUR 110.03 EUR
50 Day MA 101.47 EUR
Shares Short Prior Month
200 Day MA 101.11 EUR
Short Ratio
Shares Short
Short Percent